Dr. Walla Al-Hertani is a Medical Biochemical Geneticist and a Clinical Geneticist practicing at Boston Children’s Hospital and an Assistant Professor of Pediatrics at Harvard Medical School. She received her Doctor of Medicine degree from Dalhousie University in Halifax, Nova Scotia, followed by the completion of her Clinical Genetics residency in Ottawa and a Biochemical Genetics fellowship at the Hospital for Sick Children and the University of Toronto. Dr. Al-Hertani is currently the Director of the Lysosomal Diseases Program, Glycogen Storage Diseases Program and the Assistant Director of the Metabolism Program at Boston Children’s Hospital. She is actively involved with a number of clinical trials investigating innovative therapies for rare diseases.

Dr. Al-Hertani also specializes in inborn errors off metabolism, lysosomal storage diseases, Glycogen Storage Diseases, Gaucher disease, Pompe Disease, Niemann Pick Disease Type C, MPSI, MPSII, MPSIII, MPSIVA, MPSVI, GSD1a, GSD1b, GSD3, GSD6, GSD9, Methylmalonic acidemia, Propionic acidemia, X-Linked Adrenoleukodystrophy, Peroxisomal disorders, Mitochondrial disorders and Genetic disorders.

Share

Discuss in Social Wall

Share to rareTeam

Bookmark